2009
DOI: 10.1016/j.fct.2008.11.027
|View full text |Cite
|
Sign up to set email alerts
|

Anti-inflammatory and hypolipemic effects in vitro of simvastatin comparing to epicatechin in patients with type-2 hypercholesterolemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 28 publications
0
12
0
Order By: Relevance
“…nonconventional treatments for hypercholesterolemia, such as novel drugs based on a natural product, tea catechins (mainly gallate ester derivatives) have been tested successfully both in vitro and in vivo as cholesterol-lowering agents (15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25). Globally, these fi ndings indicate that catechins exert concerted, multiple-level action involving the upregulation of the LDL receptor ( 15,24 ), the reduction of cholesterol absorption ( 16,26,27 ), and the modulation of both synthetic ( 15,28,29 ) and metabolic pathways ( 24 ).…”
mentioning
confidence: 96%
“…nonconventional treatments for hypercholesterolemia, such as novel drugs based on a natural product, tea catechins (mainly gallate ester derivatives) have been tested successfully both in vitro and in vivo as cholesterol-lowering agents (15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25). Globally, these fi ndings indicate that catechins exert concerted, multiple-level action involving the upregulation of the LDL receptor ( 15,24 ), the reduction of cholesterol absorption ( 16,26,27 ), and the modulation of both synthetic ( 15,28,29 ) and metabolic pathways ( 24 ).…”
mentioning
confidence: 96%
“…This suggests that ApoE lipoproteins participate in some way in the processing of APP, perhaps by modulating APP secretases, and may also play a role in the assembly of the neuronal cytoskeleton. High cholesterol levels during mid-life increase the risk of Alzheimer's disease and lipid-lowering therapies including the consumption of wine-derived phenolic compounds can lower this risk which may accordingly lower the risk of developing Alzheimer's disease [140][141][142].…”
Section: Amyloid-β and Apoe-epsilon 4 Allelementioning
confidence: 99%
“…Anthraquinones such as rhein, chrysophanol, emodin and physcion reported to exhibit antioxidant and hypolipidemic activities (Xiao-Yan et al 2009;Sheeba et al 2010;Woojung et al 2012;Shu-Chun & Jing-Gung 2012;Brijesh et al 2014;Yan-Xi et al 2015). Flavonoids such as kaempferol, quercetin, myricetin, rutin, catechin, epicatechin, procyanidin B2 and epiafzelechin have been reported to exert antioxidant and hypolipidemic effects (Angela et al 2009;Franiak-Pietryga et al 2009;Chia et al 2011;Shamala et al 2014). It is well established that dietary phytosterol such as b-sitosterol lowers plasma cholesterol concentrations by inhibiting intestinal cholesterol absorption (Chan et al 2006).…”
Section: Discussionmentioning
confidence: 99%